LACTINESE

This brand name is authorized in Ecuador.

Active ingredients

The drug LACTINESE contains one active pharmaceutical ingredient (API):

`1`	Cabergoline UNII `LL60K9J05T` - CABERGOLINE
	Cabergoline is a dopaminergic ergoline derivative endowed with a potent and long-lasting PRL-lowering activity.
	Read more about Cabergoline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G02CB03	Cabergoline	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors
Discover more medicines within G02CB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	30188-04-12

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.